{Reference Type}: Journal Article
{Title}: Short Communication: HIV-1 Drug Resistance Mutation Analyses of Cameroon-Derived Integrase Sequences.
{Author}: Mikasi SG;Isaacs D;Ikomey GM;Shimba H;Cloete R;Jacobs GB;
{Journal}: AIDS Res Hum Retroviruses
{Volume}: 37
{Issue}: 1
{Year}: 01 2021
{Factor}: 1.723
{DOI}: 10.1089/AID.2020.0022
{Abstract}: HIV-1 integrase (IN) is a primary target for combination antiretroviral therapy. Only a limited number of studies report on the emergence of resistance-associated mutations (RAMs) in Cameroon. We observed that 1.4% of sequence from treatment-naive patients had IN strand transfer inhibitor (INSTI) RAMs. These mutations confer resistance to raltegravir and elvitegravir. We also observed that 10.1% of the sequences have INSTI accessory RAMs. HIV-1 CRF02_AG was the predominant subtype (44.7%) in this study analyses. The occurrence of INSTI RAMs among the sequences at baseline needs to be monitored carefully.